메뉴 건너뛰기




Volumn 138, Issue AUG, 2013, Pages 175-177

Treatment of irritable bowel syndrome with probiotics: Growing evidence

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIUM ANIMALIS EXTRACT; BIFIDOBACTERIUM BREVIS EXTRACT; BIFIDOBACTERIUM INFANTIS EXTRACT; LACTOBACILLUS ACIDOPHILUS EXTRACT; LACTOBACILLUS CASEI EXTRACT; LACTOBACILLUS PLANTARUM EXTRACT; LACTOBACILLUS REUTERI EXTRACT; LACTOBACILLUS RHAMNOSUS EXTRACT; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RIFAXIMIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

EID: 84883427056     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (6)

References (15)
  • 1
    • 56349126039 scopus 로고    scopus 로고
    • Efficacy of probiotics in irritable bowel syndrome: A metaanalysis of randomized, controlled trials
    • Nikfar S, Rahimi R, Rahimi F, Derakhshani S, Abdollahi M. Efficacy of probiotics in irritable bowel syndrome: a metaanalysis of randomized, controlled trials. Dis Colon Rectum 2008; 51: 1775-80.
    • (2008) Dis Colon Rectum , vol.51 , pp. 1775-1780
    • Nikfar, S.1    Rahimi, R.2    Rahimi, F.3    Derakhshani, S.4    Abdollahi, M.5
  • 2
    • 74849116063 scopus 로고    scopus 로고
    • Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    • Bixquert Jimenez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?. Rev Esp Enferm Dig 2009; 101: 553-64.
    • (2009) Rev Esp Enferm Dig , vol.101 , pp. 553-564
    • Bixquert Jimenez, M.1
  • 3
    • 67649537590 scopus 로고    scopus 로고
    • American College of Gastroenterology Task Force on Irritable Bowel Syndrome. An evidence-based position statement on the management of irritable bowel syndrome
    • Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, et al. American College of Gastroenterology Task Force on Irritable Bowel Syndrome. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 (Suppl 1): S1-S35.
    • (2009) Am J Gastroenterol , vol.104 , Issue.SUPPL. 1
    • Brandt, L.J.1    Chey, W.D.2    Foxx-Orenstein, A.E.3    Schiller, L.R.4    Schoenfeld, P.S.5    Spiegel, B.M.6
  • 4
    • 65449165950 scopus 로고    scopus 로고
    • Postinfectious irritable bowel syndrome
    • Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
    • (2009) Gastroenterology , vol.136 , pp. 1979-1988
    • Spiller, R.1    Garsed, K.2
  • 5
    • 65449172901 scopus 로고    scopus 로고
    • The utility of probiotics in the treatment of irritablde bowel syndrome: A systematic review
    • quiz 1050
    • Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritablde bowel syndrome: a systematic review. Am J Gastroenterol 2009; 104: 1033-49; quiz 1050.
    • (2009) Am J Gastroenterol , vol.104 , pp. 1033-1049
    • Brenner, D.M.1    Moeller, M.J.2    Chey, W.D.3    Schoenfeld, P.S.4
  • 7
    • 60349087099 scopus 로고    scopus 로고
    • Fermented milk containing Bifidobacterium lactis DN-173010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study
    • Guyonnet D, Woodcock A, Stefani B, Trevisan C, Hall C. Fermented milk containing Bifidobacterium lactis DN-173010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study. J Dig Dis 2009; 10: 61-70.
    • (2009) J Dig Dis , vol.10 , pp. 61-70
    • Guyonnet, D.1    Woodcock, A.2    Stefani, B.3    Trevisan, C.4    Hall, C.5
  • 8
    • 77949833947 scopus 로고    scopus 로고
    • Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis
    • Villani AC, Lemire M, Thabane M, Belisle A, Geneau G, Garg AX, et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138: 1502-13.
    • (2010) Gastroenterology , vol.138 , pp. 1502-1513
    • Villani, A.C.1    Lemire, M.2    Thabane, M.3    Belisle, A.4    Geneau, G.5    Garg, A.X.6
  • 9
    • 77749318556 scopus 로고    scopus 로고
    • The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review
    • Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325-32.
    • (2010) Gut , vol.59 , pp. 325-332
    • Moayyedi, P.1    Ford, A.C.2    Talley, N.J.3    Cremonini, F.4    Foxx-Orenstein, A.E.5    Brandt, L.J.6
  • 10
    • 78650864077 scopus 로고    scopus 로고
    • Rifaximin therapy for patients with irritable bowel syndrome without constipation
    • Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364: 22-32.
    • (2011) N Engl J Med , vol.364 , pp. 22-32
    • Pimentel, M.1    Lembo, A.2    Chey, W.D.3    Zakko, S.4    Ringel, Y.5    Yu, J.6
  • 11
    • 84857039944 scopus 로고    scopus 로고
    • The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrheadominant irritable bowel syndrome: A randomized, doubleblind, placebo-controlled trial
    • Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrheadominant irritable bowel syndrome: a randomized, doubleblind, placebo-controlled trial. J Clin Gastreonterol 2012; 46: 220-7.
    • (2012) J Clin Gastreonterol , vol.46 , pp. 220-227
    • Ki Cha, B.1    Mun Jung, S.2    Hwan Choi, C.3    Song, I.D.4    Woong Lee, H.5    Joon Kim, H.6
  • 12
    • 84856033373 scopus 로고    scopus 로고
    • Review article: Probiotics for the treatment of irritable bowel syndrome-Focus on lactic acid bacteria
    • Clarke G, Cryan JF, Dinan TG, Quigley EM. Review article: probiotics for the treatment of irritable bowel syndrome-Focus on lactic acid bacteria. Aliment Pharmacol Ther 2012; 35: 403-13.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 403-413
    • Clarke, G.1    Cryan, J.F.2    Dinan, T.G.3    Quigley, E.M.4
  • 13
    • 84875258473 scopus 로고    scopus 로고
    • Gut microbiota for health-current insights and understanding
    • Simren M, Doré J. gut microbiota for health-current insights and understanding. Eur Gastroenterol Hepatol Rev 2012; 8: 77-81.
    • (2012) Eur Gastroenterol Hepatol Rev , vol.8 , pp. 77-81
    • Simren, M.1    Doré, J.2
  • 14
    • 84860990474 scopus 로고    scopus 로고
    • British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults
    • McKenzie YA, Alder A, Anderson W, Wills A, Goddard L, Gulia P, et al. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2012; 25: 260-74.
    • (2012) J Hum Nutr Diet , vol.25 , pp. 260-274
    • McKenzie, Y.A.1    Alder, A.2    Anderson, W.3    Wills, A.4    Goddard, L.5    Gulia, P.6
  • 15
    • 84865314484 scopus 로고    scopus 로고
    • A gastroenterologist's guide to probiotics
    • Ciorba MA. A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol 2012; 10: 960-8.
    • (2012) Clin Gastroenterol Hepatol , vol.10 , pp. 960-968
    • Ciorba, M.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.